Literature DB >> 32369606

COVID-19 infection and sickle cell disease: a UK centre experience.

Kayleigh A McCloskey1, John Meenan1, Rhys Hall1, Dimitris A Tsitsikas1.   

Abstract

Entities:  

Keywords:  COVID-19; sickle cell disease

Mesh：

Year:  2020        PMID： 32369606     DOI： 10.1111/bjh.16779

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  34 in total

1.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Preventing infections in children and adults with asplenia.

Authors:  Grace M Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana.

Authors:  Seth Andrews Attoh; Emmanuel Sarkodie; Raymond Fatchu; Amma Benneh-Akwasi Kuma; Edward Asumanu; Mary McAddy; Alfred Toppar; Frederick Hobenu; Kwasi Agyeman-Bediako; Lawrence Edusei; Patrick Kafui Akakpo
Journal:  Pan Afr Med J       Date:  2022-04-25

4.  Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience.

Authors:  Preethi Ramachandran; Abhilash Perisetti; Balachandar Kathirvelu; Mahesh Gajendran; Snigdha Ghanta; Ifeanyichkwu Onukogu; Ted Lao; Faiz Anwer
Journal:  EJHaem       Date:  2020-08-30

5.  Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Jun Xin Lee; Wei Keong Chieng; Muhammad Irfan Abdul Jalal; Chai Eng Tan; Sie Chong Doris Lau
Journal:  Front Med (Lausanne)       Date:  2022-05-30

6.  SARS-CoV-2 infection in patients with sickle cell disease.

Authors:  María Argüello-Marina; Montserrat López-Rubio; Marta Morado
Journal:  Med Clin (Barc)       Date:  2021-05-11       Impact factor: 1.725

7.  Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.

Authors:  Can Boğa; Süheyl Asma; Göksel Leblebisatan; Nazan Şen; Anıl Tombak; Yusuf Ziya Demiroğlu; Mahmut Yeral; Şule Akın; Hasan Yeşilağaç; Mehmet Ali Habeşoğlu; Anış Arıboğan; Mutlu Kasar; Aslı Korur; Hakan Özdoğu
Journal:  Ann Hematol       Date:  2021-05-25       Impact factor: 3.673

Review 8.  Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.

Authors:  Modupe Coker; Morenike O Folayan; Ian C Michelow; Regina E Oladokun; Nguavese Torbunde; Nadia A Sam-Agudu
Journal:  Pediatr Res       Date:  2020-09-24       Impact factor: 3.756

Review 9.  Sickle cell disease and COVID-19: Susceptibility and severity.

Authors:  Babak Sayad; Mehran Karimi; Zohreh Rahimi
Journal:  Pediatr Blood Cancer       Date:  2021-06-01       Impact factor: 3.838

10.  How we approach thrombosis risk in children with COVID-19 infection and MIS-C.

Authors:  Anjali A Sharathkumar; E Vincent S Faustino; Clifford M Takemoto
Journal:  Pediatr Blood Cancer       Date:  2021-05-06       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.